MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

114.12 -1.32 (-1.14%)
Streaming Delayed Price Updated: 2:03 PM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
News headline image
IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year ↗
IO Biotech's Phase 3 trial showed Cylembio plus Keytruda improved progression-free survival in advanced melanoma across most subgroups. 
Via Benzinga
News headline image
2 Magnificent Stocks to Buy That Are Near 52-Week Lows ↗
These two reliable and high-yielding dividend payers from the healthcare sector should be on your buy list today. 
Via The Motley Fool
Topics Intellectual Property
News headline image
3 High-Yield Healthcare Stocks to Buy Hand Over Fist in August ↗
One reliable high-yielder, one dividend growth stock, and one turnaround story for dividend lovers in August. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
2 Cash-Producing Stocks for Long-Term Investors and 1 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Earnings Scheduled For July 29, 2025 ↗
 
Via Benzinga
News headline image
Political Tremors Rattle Markets: The Profound Impact of U.S. Elections and Tariff Shocks
The intricate dance between political shifts and financial markets has once again taken center stage, demonstrating the profound influence of electoral outcomes and subsequent policy decisions on... 
Via MarketMinute
Topics Economy Government Stocks
News headline image
Is It Time to Buy Biotech Stocks? ↗
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech? 
Via The Motley Fool
News headline image
MERCK & CO. INC. (NYSE:MRK): A Top Dividend Stock with Strong Profitability and Financial Stability ↗
Merck & Co. (MRK) is a top dividend stock with a 4.06% yield, strong profitability, and solid financials, making it a reliable choice for income investors. 
Via Chartmill
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
Their steep payouts make them worth a look, but a big dividend doesn't inherently make a stock worth owning. 
Via The Motley Fool
Topics Stocks World Trade
News headline image
Merck (MRK) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via Investor Brand Network
Topics Government
News headline image
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
EQNX::TICKER_START (NASDAQ:SNGX),(NYSE:PFE),(NYSE:MRK),(NYSE:BMY),(NASDAQ:INSM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Government
News headline image
This Biotech Stock Could Soar on Upcoming Clinical Data ↗
This weight loss drugmaker may be significantly undervalued right now. 
Via The Motley Fool
News headline image
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
3 High-Yielding Dividend Stocks That Are Trading Near Their 52-Week Lows ↗
If you are looking for dividend stocks, a good place to start is with unloved stocks like these, with yields of up to 6.4%. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...' ↗
President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences. 
Via Benzinga
Topics Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗
Via Stocktwits
Topics Government
News headline image
Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today ↗
These stocks have all surged more than 1,000% since August 2020. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns ↗
Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove investor interest. 
Via Benzinga
Topics Earnings
News headline image
Why Merck Stock Slipped Today ↗
A change in full-year guidance by management wasn't particularly welcome. 
Via The Motley Fool
News headline image
Is Merck & Co Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Why Merck (MRK) Shares Are Sliding Today
Shares of global pharmaceutical company Merck (NYSE:MRK) fell 3.2% in the afternoon session after the company reported second-quarter financial results that missed revenue expectations and revealed a... 
Via StockStory
Topics Artificial Intelligence Workforce
News headline image
Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges ↗
Merck posted lower Q2 earnings as vaccine sales dropped, but oncology and animal health segments saw strong growth; 2025 guidance slightly raised. 
Via Benzinga
News headline image
AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday? ↗
Risk appetite took a breather Tuesday, with major U.S. stock indices retreating modestly from record highs as investors braced for a pivotal stretch of earnings and macro events. 
Via Benzinga
News headline image
These S&P500 stocks are gapping in today's session ↗
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Tuesday and stay ahead of the market trends. 
Via Chartmill
News headline image
Merck’s Full Year Guidance Disappoints Investors But Retail Pins Hopes On $3B Cost-Cutting Plan ↗
The $3 billion will be reinvested to support new product launches and its pipeline across multiple therapeutic areas, Merck said. 
Via Stocktwits
Topics World Trade
News headline image
Which S&P500 stocks are moving before the opening bell on Tuesday? ↗
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Merck Posts Q2 EPS Beat Revenue Slips ↗
Via The Motley Fool
News headline image
Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations
Global pharmaceutical company Merck (NYSE:MRK) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.9% year on year to $15.81 billion. The company’s outlook for the full year was... 
Via StockStory
News headline image
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results
From Merck & Co., Inc.
Via Business Wire
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story